Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-06-24
2008-06-24
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S290000
Reexamination Certificate
active
07390817
ABSTRACT:
A method of treating conditions associated with pain and alleviating the symptoms associated therewith which comprises administering to a mammal, including man, a vanilloid VR-1 antagonist or a pharmaceutically acceptable derivative thereof and an NSAID or a pharmaceutically acceptable derivative thereof, wherein said VR-1 antagonist or said NSAID may optionally be administered as a sub-maximal amount.
REFERENCES:
patent: 6048855 (2000-04-01), Breton et al.
patent: 2004/0138454 (2004-07-01), Culshaw et al.
patent: WO/0146194 (2001-06-01), None
patent: WO/0208221 (2002-01-01), None
patent: WO/02076946 (2002-10-01), None
patent: WO/03022809 (2003-03-01), None
patent: WO/03062209 (2003-07-01), None
Bountra Charanjit
Davis John Beresford
Rami Harshad Kantilal
Thompson Mervyn
Glaxo Group Limited
Jean-Louis Samira
Marjarian William
Padmanabhan Sreeni
Venetianer Steven
LandOfFree
Combinations of a vanilloid antagonist and an NSAID for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combinations of a vanilloid antagonist and an NSAID for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of a vanilloid antagonist and an NSAID for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2810890